Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
tanj
May 21, 2024, 00:56 |
Blog
Tanja Obradovic: Carisma Therapeutics just announced that first cancer patient with solid tumor received CAR-monocyte
Tanja Obradovic shared a post on LinkedIn: ''As of yesterday new cell therapy modality may be…
May 20, 2024, 02:15 |
Insight
Tanja Obradovic: Potential of TIGIT inhibitors to boost efficacy of PD(L)-1 inhibitor immunotherapy
Tanja Obradovic shared on LinkedIn: "Questions around potential of TIGIT inhibitors to boost efficacy of PD(L)-1…
May 17, 2024, 14:37 |
Societies
Tanja Spanic: Addressing lymphedema is very important regarding QoL
Tanja Spanic, President of Europa Donna Slovenia, shared on X: . "Axillary management in the…
May 15, 2024, 09:38 |
Blog
Tanja Obradovic: Important PDUFA on June 12th is coming up
Tanja Obradovic shared a post on LinkedIn: "Important PDUFA on June 12th is coming up that…
May 15, 2024, 08:32 |
Blog
Tanja Obradovic: Private Biotech investment is on the steady rise reaching $3.1 billion in April
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: “Private Biotech investment is…
May 15, 2024, 04:12 |
Blog
Tanja Obradovic: News about effectiveness of PD-1 inhibitors in endometrial cancer continues to paint complex picture
Tanja Obradovic shared on LinkedIn: ''News about effectiveness of PD-1 inhibitors in endometrial cancer continues…
May 14, 2024, 11:07 |
Blog
Tanja Obradovic: At ASCO 2024 at the ICON plc booth we share thoughts on latest in cancer treatment innovation
Tanja Obradovic shared a post by ICON plc on LinkedIn, adding: ''This year we are certain…
May 12, 2024, 07:27 |
Drugs
Tanja Obradovic summarizes the latest news on immunotherapy with chemoradiation NSCLC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: “Based on what…
May 3, 2024, 23:43 |
Blog
Tanja Obradovic: All eyes are on ADCs coming from China's biotech innovation engine and CAR-T cell therapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on…
May 3, 2024, 04:53 |
Blog
Tanja Obradovic: Herceptin biosimilar Hercessi has just been approved by FDA
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on LinkedIn:…
2
3
4
5
6
All:
74
Posts:
31 - 40
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube